A MULTICENTER, RANDOMIZED, INVESTIGATOR- AND SUBJECT-BLIND, PLACEBO-CONTROLLED, TREATMENT SEQUENCE STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF UCB7665 IN SUBJECTS WITH MODERATE TO SEVERE MYASTHENIA GRAVIS
Clinical Trial Grant
Administered By
Neurology, Neuromuscular Disease
Awarded By
UCB Biosciences Inc.
Start Date
June 19, 2017
End Date
July 31, 2020
Administered By
Neurology, Neuromuscular Disease
Awarded By
UCB Biosciences Inc.
Start Date
June 19, 2017
End Date
July 31, 2020